Zenith Drugs Ltd
ZENITHDRUGZenith Drugs Ltd
ZENITHDRUG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹139 cr, stock is ranked 2,814
High RiskStock is 4.92x as volatile as Nifty
81.203.16% (-2.65)
81.203.16% (-2.65)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 2.23 | 0.62% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.49 | 6.67 | 0.52% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Zenith Drugs is an India-based pharmaceutical manufacturing and trading company.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
46.13
1Y Return
47.60%
Buy Reco %
80.00
Cipla Ltd
PE Ratio
29.21
1Y Return
19.73%
Buy Reco %
70.97
Mankind Pharma Ltd
PE Ratio
62.91
1Y Return
51.46%
Buy Reco %
80.00
Torrent Pharmaceuticals Ltd
PE Ratio
69.91
1Y Return
49.91%
Buy Reco %
74.07
Dr Reddy's Laboratories Ltd
PE Ratio
20.24
1Y Return
20.30%
Buy Reco %
37.50
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 92.67 | 115.76 | 133.90 | — | ||||
Raw Materials | 49.14 | 45.52 | 36.41 | — | ||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | |||||
| Employee Cost | 2.84 | 4.09 | 5.34 | |||||
| Selling & Administrative Expenses | 6.53 | 15.59 | 15.63 | |||||
| Operating & Other expenses | 26.19 | 40.27 | 58.77 | |||||
EBITDA | 7.97 | 10.29 | 17.75 | — | ||||
| Depreciation/Amortization | 1.33 | 1.31 | 1.30 | — | ||||
| PBIT | 6.64 | 8.98 | 16.45 | — | ||||
| Interest & Other Items | 2.24 | 2.33 | 3.00 | — | ||||
| PBT | 4.40 | 6.65 | 13.45 | — | ||||
| Taxes & Other Items | 1.27 | 1.78 | 3.84 | — | ||||
| Net Income | 3.13 | 4.87 | 9.61 | — | ||||
| EPS | 78.25 | 121.75 | 10.95 | — | ||||
| DPS | 0.00 | 0.00 | 0.50 | — | ||||
| Payout ratio | 0.00 | 0.00 | 0.05 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zenith Drugs Ltd | 14.49 | 2.23 | 0.62% |
| Sun Pharmaceutical Industries Ltd | 46.13 | 6.58 | 0.73% |
| Cipla Ltd | 29.21 | 4.49 | 0.87% |
| Mankind Pharma Ltd | 62.91 | 12.57 | — |
Price Comparison
Compare ZENITHDRUG with any stock or ETFCompare ZENITHDRUG with any stock or ETF
ZENITHDRUG
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Feb 2024
Mar 2024
Sep 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 17, 2024
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2024
News & Opinions
Articles & Videos
Corporate
Zenith Drugs to table results
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
1 month agoCapital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant